OPX Biotechnologies, Inc. Email Formats	Example	Percentage
FLast@opxbiotechnologies.com	JDoe@opxbiotechnologies.com	50%
FLast@opxbiotechnologies.com	JDoe@opxbiotechnologies.com	50%

Where is OPX Biotechnologies, Inc.'s headquarters located?

OPX Biotechnologies, Inc.'s main headquarters is located at 2425 55th Street, Suite 100. The company has employees across 2 continents, including North AmericaOceania.

What is OPX Biotechnologies, Inc.'s official website and social media links?

OPX Biotechnologies, Inc.'s official website is opxbiotechnologies.com and has social profiles on LinkedIn.

What is OPX Biotechnologies, Inc.'s SIC code NAICS code?

OPX Biotechnologies, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OPX Biotechnologies, Inc. have currently?

As of December 2025, OPX Biotechnologies, Inc. has approximately 51 employees across 2 continents, including North AmericaOceania. Key team members include Senior Research Associate: D. R.Executive Administrator: S. W.Supply Chain Specialist: T. G.. Explore OPX Biotechnologies, Inc.'s employee directory with LeadIQ.

What industry does OPX Biotechnologies, Inc. belong to?

OPX Biotechnologies, Inc. operates in the Biotechnology Research industry.

What is OPX Biotechnologies, Inc.'s email format?

OPX Biotechnologies, Inc.'s email format typically follows the pattern of FLast@opxbiotechnologies.com. Find more OPX Biotechnologies, Inc. email formats with LeadIQ.

OPX Biotechnologies, Inc.

Q: How many employees does OPX Biotechnologies, Inc. have currently?

OPX Biotechnologies, Inc. has approximately 51 employees.

Biotechnology ResearchColorado, United States51-200 Employees

At OPXBIO, we’re in the Good Chemistry business. We develop and produce bio-based chemicals and fuels that deliver more sustainable value to our customers. Good Chemistry is everything we do. It is how we use our leading EDGE™ biotechnology to bring new products to market faster. It’s our strategic partnerships. It’s our high-performing team. And it’s our inspiration to transform the business of chemistry to a more sustainable future. OPXBIO will be the first company to sell BioAcrylic for direct replacement of petro-acrylic in the existing $10 billion global market with applications in diapers, detergents, paints, and adhesives. In 2011, OPXBIO reached agreement with The Dow Chemical Company to jointly develop the industrial-scale process for BioAcrylic. OPXBIO has demonstrated lab scale production of its second product – fatty acid from syngas feedstock for chemical and fuel applications. A $6 million award from the US DOE ARPA-E agency supports this development. OPXBIO was founded in 2007 and currently employs 65 people. The company completed its latest financing in 2011, raising $41 million from venture capital investors Mohr Davidow Ventures, US Renewables Group, Braemar Energy Ventures, Altira Group, DBL Investors, Wolfenson Capital Partners, and X/Seed Capital. www.opxbio.com

Insights

Similar companies to OPX Biotechnologies, Inc.

BASF

Amyris

DuPont

Novozymes

DSM

Cargill